Efficiency of Vitrectomy in Diabetic Macular Edema and Morphometry of Surgically Removed of the Internal Limiting Membrane

Authors: J. Kalvoda 1;  J. Dušková 2;  Z. Kovařík 1;  A. Kuběna 3;  B. Kalvodová 1
Authors‘ workplace: Oční klinika, 1. lékařská fakulta, Univerzita Karlova v Praze a Všeobecná fakultní nemocnice, Praha, přednostka doc. MUDr. Bohdana Kalvodová, CSc., 2Ústav patologie, 1. lékařská fakulta, Univerzita Karlova v Praze a Všeobecná fakultní nemocnice, Praha, př 1
Published in: Čes. a slov. Oftal., 66, 2010, No. 2, p. 76-82


To evaluate the efficiency of vitrectomy with peeling of the internal limiting membrane (ILM) in eyes with diffuse and/or cystoid nontractional diabetic macular edema (ME) refractory to macular laser photocoagulation. Histopathologic and morphometric analysis of the ILM in diabetic eyes was performed. Thickness of the ILM was correlated with the level of glykosylated hemoglobin (HbA1C) and other clinical factors.

Material and methods:
The prospective study involved 56 eyes of 52 diabetic patients with a mean age of 63 ± 7.6 years. Vitrectomy with trypan blue-assisted ILM peeling was performed in standard way. Mean follow-up period was 8.7 months (range 3 – 19 months). The ILM was fixed immediately after peeling in 2.5 % glutaraldehyde and submitted for electron microscopic evaluation. The ILM was photographed in standard magnification (x 5000) with the scale of 1 μm in the shot.

Statistical analysis of the postoperative visual acuity (VA) in the study group of 56 eyes proved a general improvement with prevalence of the resulted VA in intervals 0.1–0.2 and 0.5–1.0 related to ETDRS chart. The VA was improved by at least 2 lines in 29 eyes of 56 eyes (51.8%), one line in 6 eyes (10.7%) and remained unchanged in 11 eyes (19.6%). The postoperative VA deteriorated by one line in 2 eyes (3.6%) and at least 2 lines in 8 eyes (14.3%). Morphometric analysis demonstrated a significant thickening of the ILM in all eyes with a mean thickness of the ILM 3.61 ± 1.22 μ m. It was found that a higher thickness of the ILM is related to elevated HbA1C by both types of diabetes mellitus (DM) (p = 0.040). We also found significant dependence of ILM thickness in relation to duration of DM by comparison of men and women (p = 0.026) and significant correlation between ILM thickness and the age of diabetic patients related to their gender (p = 0.029).

Vitrectomy with peeling of the ILM in eyes with chronic diffuse and/or cystoid nontractional diabetic ME mildly improves the VA and extends a hope for its stabilization. We confirmed increased thickness of the surgically peeled ILM and statistically significant correlations to elevated HbA1C by both types of DM and to further clinical characteristics of case series. Morphometric and histopathologic analyses of the ILM contribute to more objective evaluation of ultrastructure of the vitreomacular interface.

Key words:
diabetic macular edema, internal limiting membrane, morphometry, vitrectomy, glykosylated hemoglobin


1. Avci, R., Kaderli, B., Avci, B. et al.: Pars plana vitrectomy and removal of the internal limiting membrane in the treatment of chronic macular oedema. Graefe’s Arch. Exp.Ophthalmol., 2004, 242: 845–852.

2. Bron, A.J., Tripathi, R.C., Tripathi, B.J.: The inner limiting membrane. In Wolff’’s anatomy of the eye, Chapman & Hall, 1997, 488 p.

3. Dillinger, P., Mester, U.: Vitrectomy with removal of the internal limiting membrane in chronic diabetic macular edema. Graefe’s Arch. Clin. Exp. Ophthalmol., 2004, 242: 630–637.

4. Do, D.V., Shah, S.M., Sung, J.U. et al.: Persistent diabetic macular edema is associated with elevated Hemoglobin A1c. Am. J. Ophthalmol., 2005, 139: 620–623.

5. Doi, N., Uemura, A., Nakao, K. et al.: Vitreomacular adhesion and the defect in posterior vitreous cortex visualized by triamcinolone-assisted vitrectomy. Retina, 2005, 25: 742–745.

6. Ducournau, D., Ducournau, Y.: A Closer Look at the ILM. Removal of the ILM induces a cellular response that allows the retina to fight against edema. A Supplement to Retinal Physician, 2008, July/August: 4–15.

7. Figueroa, M.S., Contreras, I., Noval, S.: Surgical and anatomical outcomes of pars plana vitrectomy for diffuse nontractional diabetic macular edema. Retina, 2008, 28: 420–428.

8. Foss, R.I.: Vitreoretinal juncture: topographical variations. Invest. Ophthalmol., 1972, 11: 801-808.

9. Gandorfer, A., Messmer, E.M., Ulbig, M.W. et al.: Resolution of diabetic macular edema after surgical removal of the posterior hyaloids and the inner limiting membrane. Retina, 2000, 20: 126–133.

10. Hartley, K.L., Smiddy, W., Flynn, J.R.H. et al.: Pars plana vitrectomy with internal limiting membrane peeling for diabetic macular edema. Retina, 2008, 28: 410–419.

11. Ikeda, T., Sato, K., Katano, T. et al.: Vitrectomy for cystoid macular oedema with attached posterior hyaloid membrane in patients with diabetes. Br. J. Ophthalmol., 1999, 83: 12–14.

12. Joussen, A.M., Naumann, G.O., Coupland, S.E. et al.: Retina and Vitreous. In Neumann, G.O., Holbach, L., Kruse, F.E. et al. Applied pathology for ophthalmic microsurgeons. Springer, Berlin Heidelberg New York, 2008, pp 306–307.

13. Kalvodová, B., Záhlava, J.: Results of vitrectomy in cystoid diabetic macular edema detected by optical coherence tomography. Čes. a slov. Oftal., 2002, 58: 224–232.

14. Kimura, T., Kiryu, J., Nishiwaki, H. et al.: Efficacy of surgical removal of the internal limiting membrane in diabetic cystoid macular edema. Retina, 2005, 25: 454–461.

15. Kojima, T., Terasami, H., Nomura, H. et al.: Vitrectomy for diabetic macular edema: effect of glycemic control (HbA1c), renal function (creatinine) and other local factors. Ophthalmic Res., 2003, 35: 192–198.

16. Kuhn, F., Kiss, G., Mester, V. et al.: Vitrectomy with internal limiting membrane removal for clinically significant macular oedema. Graefe’s Arch. Exp. Ophthalmol., 2004, 242: 402–408.

17. Kumagai, K., Furukawa, M., Ogino, N. et al.: Vitreous surgery with and without internal limiting membrane peeling for macular hole repair. Retina, 2004, 24: 721–727.

18. La Heij, E.C., Dieudonné, S.C., Mooy, C.M. et al.: Immunohistochemical analysis of the internal limiting membrane peeled with indocyanine green. Am. J. Ophthalmol., 2005, 140: 1123–1125.

19. Lewis, H., Abrams, G.W., Blumenkranz, M.S. et al.: Vitrectomy for diabetic macular traction and edema associated with posterior hyaloids traction. Ophthalmology, 1999, 99: 753–759.

20. Matsunaga, N., Ozeki, H., Hirabayashi, Y. et al.: Histopathologic evaluation of the limiting membrane surgically excised from eyes with diabetic maculopathy. Retina, 2005, 25: 311–316.

21. Patel, J.I., Hykin, P.G., Schadt, M., et al.: Pars plana vitrectomy with and without peeling of the inner limiting membrane for diabetic macular edema. Retina, 2008, 26: 5–13.

22. Pendergast, S., Margherio, R., Williams, G. et al.: Vitrectomy for chronic pseudophakic cystoid macular edema. Am. J. Ophthalmol., 1999, 128: 317–323.

23. Peyman, G.A., Cheema, R,. Conway, M.D. et al.: Triamcinolone acetonide as an aid to visualization of the vitreous and the posterior hyaloids during pars plana vitrectomy. Retina, 2000, 20: 54–555.

24. Sakamoto, T., Miyazaki, M., Hisatomi, T, et al.: Triamcinolone-assisted pars plana vitrectomy improves the surgical procedures and decreases the postoperative blood-ocular barrier breakdown. Graefe’s Arch. Exp. Ophthalmol., 2002, 240: 423–429.

25. Sebag J.: Age-related differences in the human vitreoretinal interface. Arch. Ophthalmol., 1991, 109: 966-971.

26. Sonoda, K.H., Sakamoto, T., Enaida, H. et al.: Residual vitreous separation visualized by intravitreous triamcinolone acetonide. Ophthalmology, 2004, 111: 226–230.

27. Stefaniotou, M., Aspiotis, M., Kalogeropoulos, C. et al.: Vitrectomy results for diffuse diabetic macular edema with and without inner limiting membrane removal. Eur. J. Ophthalmol., 2004, 14: 137–143.

28. Tachi N, Ogino N.: Vitrectomy for diffuse macular edema in cases of diabetic retinopathy. Am. J. Ophthalmol., 1996, 122: 258–260.

29. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin dependent diabetes. N. Engl. J. Med., 1993, 329: 977–986.

30. United Kingdom Prospective Diabetes Study Group: Tight blood pressure control and risk of macrovascular and microvascular complications in Type 2 diabetes. UKPDS 38. Br. Med. J., 1998, 317: 703–713.

Forgotten password

Don‘t have an account?  Create new account

Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.


Don‘t have an account?  Create new account